RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 62 filers reported holding RA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,296,000 | +150.4% | 47,824 | +144.8% | 0.00% | – |
| Q4 2019 | $917,000 | -65.3% | 19,532 | -82.5% | 0.00% | -100.0% |
| Q3 2019 | $2,646,000 | +244.5% | 111,881 | +338.0% | 0.00% | – |
| Q2 2019 | $768,000 | +1773.2% | 25,544 | +1297.4% | 0.00% | – |
| Q1 2019 | $41,000 | +36.7% | 1,828 | +12.1% | 0.00% | – |
| Q4 2018 | $30,000 | -41.2% | 1,630 | -68.5% | 0.00% | – |
| Q2 2018 | $51,000 | -80.3% | 5,171 | -89.4% | 0.00% | – |
| Q1 2018 | $259,000 | +4216.7% | 48,753 | +12305.3% | 0.00% | – |
| Q3 2017 | $6,000 | -99.5% | 393 | -99.4% | 0.00% | -100.0% |
| Q2 2017 | $1,230,000 | +3867.7% | 65,634 | +4380.1% | 0.00% | – |
| Q1 2017 | $31,000 | -13.9% | 1,465 | -38.7% | 0.00% | – |
| Q4 2016 | $36,000 | – | 2,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |